EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

Marko Babjuk(Charles University), Andreas Böhle(Helios Kliniken), Maximilian Burger(University of Regensburg), Otakar Čapoun(Charles University), Daniel L. Cohen(Imperial College London), Éva Compérat(Sorbonne Université), Virginia Hernández(Hospital Universitario Fundación Alcorcón), Eero Kaasinen(Hyvinkää Hospital), Joan Palou(Puigvert Foundation), Morgan Rouprêt(Onco-Urologie Prédictive), Bas W.G. van Rhijn(The Netherlands Cancer Institute), Shahrokh F. Shariat(Vienna General Hospital), Viktor Soukup(Charles University), Richard Sylvester, Richard Zigeuner(Medical University of Graz)
European Urology
June 20, 2016
10.1016/j.eururo.2016.05.041
Cited by 2,295

Abstract

Related Papers

TNM Classification of Malignant Tumours
|Unknown|1987|16.1k
EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin
Samantha Cambier, Richard Sylvester, Laurence Collette et al.|European Urology|2015|634
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa–pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?
Richard Sylvester, Willem Oosterlinck, Sten Holmäng et al.|European Urology|2015|386
A systematic review of intravesical bacillus Calmette‐Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer
M. Shelley, Howard Kynaston, J.B. Court et al.|British Journal of Urology|2001|308
Methods to Improve Efficacy of Intravesical Mitomycin C: Results of a Randomized Phase III Trial
Jessie L.‐S. Au, Robert A. Badalament, M. Guillaume Wientjes et al.|JNCI Journal of the National Cancer Institute|2001|305